PD-L1 IHC 22-C3 pharmDx (Dako)

	Next higher product group	pharmacodiagnostic test (PDx)
	Status	2016-10-24 sales existent
	Organisation	Agilent Technologies Inc. (NYSE: A)
	Organisation 2	Merck & Co. Inc. (NYSE: MRK)
	Group	Merck (US) (MSD) (Group)

Record changed: 2023-07-10

Picture Kenes Exhibitions Biomed Israel 2025 Tel Aviv 650x200px

More documents for pharmacodiagnostic test (PDx)

[1] Agilent Technologies Inc.. (12/10/24). "Press Release: Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification". Santa Clara, CA....
[2] Agilent Technologies Inc.. (10/2/19). "Press Release: Agilent Receives Approval for First PD-L1 Companion Diagnostic in China". Santa Clara, CA....
[3] Agilent Technologies Inc.. (6/11/19). "Press Release: Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC)". Santa Clara, CA....
[4] Oncimmune Holdings plc. (3/19/19). "Press Release: Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling". Cambridge, MA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com